entertainment -WSS

entertainment

author：entertainment 2025-09-30 00:49:11 - browse：4

Sanofi, the Paris-based drug giant, announced Friday that it would spin out its $5 billion consumer health division, which is exploring over-the-counter moves for the erectile dysfunction drug Cialis and the flu treatment Tamiflu.

Investors reacted swiftly, bidding Sanofi’s American depository receipts on the New York Stock Exchange down nearly 18% to less than $44 in morning trading. Jared Holz, an analyst at Mizuho, warned investors that the drop “would be the largest negative single-day stock move across Global Pharma in more than ten years.”

It would be tempting to take the stock move as evidence that investors have finally tired of watching drug companies treat consumer product divisions like baseball trading cards, buying them at a high price only to sell them again a decade later. But the move probably has little to do with the current passion for pharma spinouts or with Sanofi following in the footsteps of GSK, Novartis, and Pfizer in shedding a division. Or even, for that matter, Sanofi, which shed its pharmaceutical ingredients business, EuroAPI, which is now trading at a third of its initial public offering price.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Latest bird flu infection made farmworker sicker than earlier cases

WSS

Questions and answers about ramping up H5N1 bird flu vaccine

FDA poised to publish guidelines for clinical trial diversity

Akili, maker of video game for ADHD, to be acquired for 34 million

As a primary care physician, here's how I hope to partner with AI

As a primary care physician, here's how I hope to partner with AI

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

knowledge

entertainment

entertainment

What does generative AI mean for health care? We asked experts

David Sabatini, ex

Trump demands the U.S. pay no more for drugs than other countries … again

Heat waves linked to early deliveries, preterm births in new study

In age of alternative facts, a scholarly course on calling out crap

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

Activists slam private health insurers over coverage restrictions

As a primary care physician, here's how I hope to partner with AI

Walensky prepares to leave CDC — and Congress — behind

David Sabatini, ex

entertainment

Addiction doctors spar with methadone clinics over legislation

Adam's Biotech Scorecard: Do Sarepta's exon

Scientists successfully use ultrasound imaging to map brain activity

Addressing health care workers' trauma can help fight burnout

Fentanyl is making it harder to start addiction treatment

First Opinion Podcast: What happens when kids become caregivers?

leisure time

hotspot

hotspot

knowledge